SBI Securities
CATX icon

SBI Securities’s Perspective Therapeutics CATX Stock Holding History

SBI Securities’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.14K Buy
415
+414
+41,400% +$1.26K ﹤0.01% 2808
2026
Q2 		$3 Hold
1
– – ﹤0.01% 4017
2026
Q1 		$4 Hold
1
– – ﹤0.01% 3926
2025
Q4 		$3 Hold
1
– – ﹤0.01% 3954
2025
Q3 		$3 Hold
1
– – ﹤0.01% 4125
2025
Q2 		$3 Hold
1
– – ﹤0.01% 4091
2025
Q1 		$2 Hold
1
– – ﹤0.01% 4085
2024
Q4 		$3 Buy
+1
New +$8 ﹤0.01% 4031

Other funds holding CATX

WealthPlan Investment Management
WealthPlan Investment Management Omaha, Nebraska $2.07B AUM 21.2% 1-Year Est. Return
Taylor & Morgan Wealth Management
Taylor & Morgan Wealth Management Flint, Michigan $208M AUM 15.78% 1-Year Est. Return
Koa Wealth Management
Koa Wealth Management Encinitas, California $154M AUM 13.16% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Iowa State Bank
Iowa State Bank Urbandale, Iowa $592M AUM 21.15% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

SBI Securities's CATX Position: Q3 2026 in Review

SBI Securities increased its Perspective Therapeutics (CATX) stake by 41,400% in Q3 2026, buying an estimated $1.26K and bringing the position to 415 shares worth $1.14K. The position accounts for ﹤0.01% of the portfolio, ranked #2808.

SBI Securities first reported a position in CATX in Q4 2024 and has held it in 8 quarters since. 10 funds tracked by Wall St. Rank hold CATX as of Q3 2026.

  • SBI Securities held 415 shares of Perspective Therapeutics worth $1.14K as of Q3 2026.
  • SBI Securities bought 414 Perspective Therapeutics shares in Q3 2026, an estimated $1.26K.
  • Perspective Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #2808 holding.
  • SBI Securities first reported a position in Perspective Therapeutics in Q4 2024 and has held it in 8 quarters since.
  • 10 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.